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A stable cell system for high-efficiency packaging of West Nile virus (WNV) subgenomic replicons into virus-like particles (VLPs) was
developed. VLPs could be propagated on these packaging cells and produced infectious foci similar to foci produced by WNV. Focus size
correlated with the replicative capacity of WNV replicons, indicating that genome copy number, rather than amount of trans-complementing
structural proteins, was rate-limiting in packaging of VLPs. Comparison of VLP production from replicon genomes encoding partial or complete
C genes indicated that portions of C downstream of the cyclization sequence could improve genome replication or that cis expression of C could
enhance packaging. Interestingly, a rapid loss of replicon-encoded reporter gene activity was detected within two serial passages of reporter gene-
containing VLPs. The loss of reporter activity correlated with gene deletion and better VLP growth, indicating a powerful selection pressure for
WNV genomes lacking reporter genes.
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West Nile virus (WNV) has widely spread in the USA since
its introduction in 1999 and poses a significant threat to public
health by producing large numbers of neuroinvasive infections
that can cause death or serious sequelae. Like other flaviviruses,
WNV has a single-stranded, positive-sense RNA of about 11 kb
in length that encodes a single polyprotein that is co- and post-
translationally cleaved into 3 structural and 7 nonstructural
proteins (Chambers et al., 1990).
To study flavivirus replication, genetic engineering has been
used to generate self-replicating flavivirus genomes (replicons)
lacking the structural protein-encoding region (Gehrke et al.,
2003; Jones et al., 2005; Khromykh and Westaway, 1997; Pang⁎ Corresponding author. Department of Pathology, 3.206B Mary Moody
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doi:10.1016/j.virol.2006.02.036et al., 2001; Shi et al., 2002). In the case of WNV, we have
recently shown that cells expressing high levels of the missing
WNV structural proteins (C, prM, and E) produced by a
genetically engineered Sindbis virus replicon, could be used to
package WNV replicons into infectious virus-like particles
(VLPs) capable of undergoing a single round of infection in
normal cells (Scholle et al., 2004). Other systems have been
described for packaging flavivirus replicons, including Kunjin
virus replicons (Harvey et al., 2004; Khromykh et al., 1998),
yellow fever virus replicons (Jones et al., 2005), tick-borne
encephalitis virus (TBEV) replicons (Gehrke et al., 2003), and
WNV replicons (Hanna et al., 2005; Puig-Basagoiti et al.,
2005). In some cases, these packaging systems have utilized cell
lines (Gehrke et al., 2003; Harvey et al., 2004) expressing the
flavivirus structural proteins under control of eukaryotic
promoters. In both of these reports, spread of infection by
replicons on packaging cell lines was noted (Gehrke et al.,
2003; Harvey et al., 2004), and one reported the ability to
repeatedly repackage replicons (Gehrke et al., 2003). These
VLP-generating systems have been useful for packaging VLP
genomes encoding various reporter genes (Jones et al., 2005;
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(Harvey et al., 2003), the study of virus tropism in an arthropod
vector (Scholle et al., 2004), and various aspects of viral
assembly and entry (Hanna et al., 2005). The use of VLPs for
some applications can be limited by modest titers that are
produced by various packaging approaches and/or lengthy and
inconvenient VLP production protocols.
Here we describe the development of cell lines selected to
persistently harbor noncytopathic subgenomic replicons of
Venezuelan equine encephalitis virus (VEEV) encoding puro-
mycin N-acetyl transferase (pac) and the WNV C/prM/E
cassette. Using these replicons, cell lines that expressed high
levels of WNV structural proteins were rapidly generated.
These cell lines were shown to be useful for amplifying VLP
stocks and comparing the replication capacity of WNV
replicons with different genetic structures. In addition, we
have used these packaging cell lines to demonstrate that WNV
replicons encoding reporter genes are genetically unstable,
losing reporter gene activity upon repeated rounds of infection
and amplification in packaging cell lines.
Results
Correlation of VLP burst size on packaging cell lines with
replicon RNA levels
Multiple laboratories have shown that flavivirus subgenomic
replicons lacking the structural protein genes are unable to
spread cell-to-cell. In contrast, when introduced into packaging
cells, subgenomic replicons can undergo repeated packaging
and infection cycles, utilizing the structural proteins supplied by
the cell, producing virus-like particles (VLPs) that result in a
spreading infection similar to that observed for live WNV
(Gehrke et al., 2003; Jones et al., 2005; Khromykh and
Westaway, 1997; Pang et al., 2001; Shi et al., 2002) (see
Introduction). To generate cells capable of packaging WNV, we
constructed plasmid DNAs encoding noncytopathic VEEV
replicons expressing pac and the WNV C/prM/E cassette (see
Fig. 1B), and then introduced their in vitro-synthesized VEEV
replicon RNAs into BHK cells and selected C/prM/E-expres-
sing cells by treatment with puromycin (Pur). As expected, the
selected cells expressed both WNVand VEEVantigens (results
not shown). Our initial characterization of Pur-resistant (PurR)
VEErep/C-E/Pac-transfected BHK cells (BHK(VEErep/C-E/
Pac)) demonstrated that these cells produced VLPs when
transfected with either of three different WNV replicon RNAs:
(1) a synthetic RNA of a minimal WNV replicon (WNR NS1-5;
see Fig. 1A), (2) a synthetic RNA of a WNV replicon containing
an antibiotic resistance gene (WNR NS1-5ET2AN; see Fig.
1A), or (3) a replicon RNA (designated WNR cl 1.1) which was
harvested from Huh7 cl 1.1 cells harboring a cell-adapted
derivative of WNR NS1-5ET2AN which replicates to a very
low level (see Fig. 1A).
To characterize the infection of the packaging cells with
these three different replicons, monolayers of BHK(VEErep/
C-E/Pac) cells were infected at low multiplicity with these three
VLPs, overlaid with a semisolid overlay to slow VLP diffusion,and then immunostained with an antibody specific for WNV
NS1. Evaluation of the immunostained foci formed by these
VLPs on BHK(VEErep/C-E/Pac) cells revealed that focus size
increased with incubation time (Fig. 2A), and that the size of the
foci correlated with our previously reported levels of WNV
antigen expression observed in cells transfected with these
replicons (Rossi et al., 2005). Specifically, the WNR NS1-5 foci
were much larger than the WNR NS1-5ET2AN foci, which, in
turn, were larger than the foci obtained with the WNR cl 1.1
replicon (Fig. 2A). Interestingly, cytopathic effect (CPE) was
visible in BHK(VEErep/C-E/Pac) cultures infected with VLPs
containing WNR NS1-5 (results not shown) and cytopathic
plaques were visible within the immunostained foci formed on
these cells with the WNR NS1-5 and WNR NS1-5ET2AN
VLPs (Fig. 2A), but not in the foci formed with WNR cl 1.1. To
further characterize the phenotype of these three WNV
replicons, we calculated the WNV genome copy number in
cells infected with these VLPs, by a quantitative dot-blot assay
(see Materials and methods). Fig. 2B shows the linear
relationship between the genome copy number of these
replicons in BHK cells (abscissa) and focus size (ordinate) on
monolayers of packaging cells. Growth curves of these VLPs on
BHK(VEErep/C-E/Pac) cells (Fig. 2C) confirm the poor
replication properties of the cl 1.1 VLPs, consistent with the
low level of replication of the Huh7 cl 1.1-adapted replicon,
which we hypothesized is the basis for its ability to persist in
Huh7 cells (Rossi et al., 2005).
Expression of WNV structural cassette by a single subgenomic
VEEV replicon is stable in BHK cells
When RNAs encoding the double-subgenomic promoter
VEEV replicon (VEErep/C-E/Pac) were introduced into BHK
cells using electroporation, a high percentage of the cells was
immunopositive for both VEEV and WNV proteins. Selection
of these transfected cultures with Pur resulted in the loss of cells
that did not express the VEEV replicon, and efficient formation
of PurR colonies as expected (Fig. 3A). However, these PurR
cultures also accumulated cells that no longer expressed WNV
antigens (Fig. 3B), suggesting genetic instability of the double-
subgenomic VEEV replicon in these pooled cell cultures, and a
selective advantage of WNV antigen-negative cells. In an
attempt to overcome this problem, individual cell clones were
isolated, and their analysis revealed that clones expressing high
levels of WNV antigen grew more poorly than clones lacking
WNV antigen expression (results not shown). These findings
were consistent with the possibility that WNV structural
proteins were toxic, as we previously observed with cells
expressing fusion-competent forms of the JEV prM/E (Konishi
et al., 2001). However, we predicted that the fusion-competent
forms of prM/E would not be efficiently produced in the BHK
(VEErep/C-E/Pac) cells, since NS2B/NS3 is required for
efficient prM/E particle formation if prM/E are co-expressed
with C (Konishi and Mason, 1993; Yamshchikov and Compans,
1994). Thus, the C/prM/E polyprotein or fragments thereof may
exhibit some level of toxicity in these cells, or a low level of
signal peptidase cleavage at the C-prM junction may produce a
Fig. 1. Schematic diagrams showing the replicons used in this study. (A) WNR NS1-5, WNR NS1-5ET2AN, and a cell-adapted form of WNR NS1-5ET2AN (WNR cl
1.1) have been described (see Materials and methods). RepliconWNR C-Luc2A NS1-5 andWNR C-bgal NS1-5 were created from a genome-length infectious cDNA
of WNV using standard techniques (see Materials and methods). (B) VEEV replicons were derived from replicon VEErep/Pac (5′VEErep/S/Pac), a noncytopathic
replicon that was described in Petrakova et al. (2005). * indicates the position of 36 clustered silent mutations at start of C (found in VEErep/C*-E/Pac and VEErep/C*-
E*-Pac) or 32 clustered silent mutations in the signal peptide of NS1 (found in VEErep/C*-E*-Pac).
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packaging cells.
To overcome the genetic instability problem observed in
the VEErep/C-E/Pac double-subgenomic promoter VEEV
replicon, we created a single-subgenomic promoter VEEV
replicon (VEErep/C*-E*-Pac) in which the WNV structural
genes were fused to the pac gene (see Materials and methods
and Fig. 1B). When introduced into BHK cells, replicon
VEErep/C*-E*-Pac conferred Pur resistance (Fig. 3C), and
essentially all of the cells in PurR colonies were immunopo-
sitive for WNVantigens (Fig. 3D), in contrast to PurR colonies
produced by replicon VEErep/C-E/Pac, where E-negative cells
were present in every PurR colony (Fig. 3B). Colonies
expressing the VEErep/C*-E*-Pac replicon (Fig. 3C) were
generally smaller in size than colonies expressing the VEErep/
C-E/Pac replicon (Fig. 3A), consistent with the toxic effects of
expression of the WNV cassette (see above). When assayed
for the amount of WNV antigen expressed at different time-points after electroporation, cultures transfected with VEErep/
C*-E*-Pac RNA produced more WNV E antigen than cultures
transfected with VEErep/C-E/Pac RNA (Fig. 3E); this finding
is explained by increased synthesis from the subgenomic
promoter driving E expression due to removal second
promoter driving Pac synthesis.
Clonal cell lines expressing single or double-subgenomic
promoter replicons produce high titers of VLPs and express
high levels of E
To examine the properties of VEEV replicon bearing cells
in more detail, we isolated individual cell clones from
cultures transfected with VEErep/C-E/Pac and VEErep/C*-
E*-Pac replicons. Immunostaining of the cloned cells revealed
that over 95% of the cells present in each of the BHK
(VEErep/C*-E*-Pac) clones expressed WNV E, whereas,
some of the BHK(VEErep/C-E/Pac) clones contained a
Fig. 2. Characterization of VLP phenotype on BHK cells replicating VEErep/C-E/Pac. (A) Immunostained foci produced on BHK(VEErep/C-E/Pac) monolayers
infected with VLPs carrying the genome structures shown in Fig. 1 {[1] WNR NS1-5, [2] WNR NS1-5ET2AN, [3] WNR cl 1.1}. (B) Correlation of genome
copy number (x-axis) in VLP infected BHK cells (note, these were not packaging cells, so spread of infection did not complicate analyses; see Materials and
methods) and size of foci present in plates shown in panel A (y-axis). (C) Release of VLPs containing replicons WNR NS1-5, WNR NS1-5ET2AN, and WNR cl
1.1 from BHK(VEErep/C-E/Pac) cells infected at an MOI of 0.01. x-axis represents time after start of infection when samples were harvested. y-axis shows titer
measured.
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Fig. 3B). To simplify evaluation of the BHK(VEErep/C-E/
Pac) clonal cells, all clones that contained more than 20%
WNV E-negative cells were discarded from subsequent
analyses. Once these clones were excluded from consider-
ation, all remaining clones obtained from the double-
subgenomic construct produced similar amounts of E-antigen
as that detected in the clones of cells expressing the single-
subgenomic construct (Fig. 4). Furthermore, high titers of
VLPs were produced by all of the clones tested (except for
clone a of BHK(VEErep/C-E/Pac)—see below; Fig. 4). The
small variations in VLP titers observed among all the clones
(except BHK(VEErep/C-E/Pac)clone a) indicated that therewere no detectable differences in the packaging efficiencies of
the proteins produced by either the single- or double-
subgenomic VEEV replicons. Furthermore, there was no
correlation between the level of WNV E-antigen and the titer
of packaged VLPs. Taken together, these results suggest that
the levels of E antigen produced in these cells are at levels
that are saturating with respect to those needed to package our
WNV replicons, and that slight differences in the amount of E
detected did not result in detectable differences in the titers of
WNV VLPs produced.
Interestingly, the single clonal packaging cell line which
showed a normal level of E production and a low level of VLP
production {BHK(VEErep/C-E/Pac)clone a; Fig. 4} was found
Fig. 3. Characterization of BHK(VEErep/C-E/Pac) and BHK(VEErep/C*-E*-Pac) cells. (A) Crystal violet-stained colonies of cells transfected with VEErep/C-E/Pac
RNAs and grown in the presence of Pur. (B) Micrograph of cells at the edge of a representative colony from the well shown in panel A (stained with MAb to WNV E
antigen prior to crystal violet staining). (C) Crystal violet-stained colonies of cells transfected with VEErep/C*-E*-Pac RNAs and grown in the presence of Pur. (D)
Micrograph of cells at the edge of a representative colony from the well shown in panel C (stained with MAb to WNV E antigen prior to crystal violet staining). (E)
Expression of WNV E antigen in BHK cells transfected with VEErep/C-E/Pac or VEErep/C*-E*-Pac RNAs. The x-axis indicates the time after electroporation and the
y-axis shows E antigen level relative to antigen level in BHK cells at 30 h after infection with WNV (this level, defined as “100”; is indicated by the thickened
horizontal line; see Materials and methods for details). Pur was added to the cultures shown in panel E at 24 h postelectroporation.
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protein. This AUG was mutated to AUA in BHK(VEErep/C-E/
Pac)clone a, requiring the WNV polyprotein to initiate at an in-
frame AUG 16 codons downstream, producing a truncated C
protein. Although this finding was not pursued, it suggests that a
truncated C can function in flavivirus assembly, albeit less
efficiently.Fig. 4. Characterization of antigen levels and VLP production from Pur selected
Individual colonies were isolated after transfection and selection with Pur; representa
analysis (see text). WNV antigen levels were determined by ELISA as described in
different clonal cell lines (linear scale, left axis; 100 corresponds to level found in WN
the titer of VLPs released from cultures of these cells at 44 h postinfection with WNClonal cell lines expressing a single-subgenomic VEEV
replicon can be passaged without a loss in packaging ability
To investigate differences in genetic stability of the WNV
insertions in the mono- and double subgenomic VEEV
replicons in their corresponding packaging cell lines in more
detail, we compared the ability of different passage levels ofBHK clones replicating VEErep/C-E/Pac and VEErep/C*-E*-Pac replicons.
tive clones with greater than 80% of cells positive for E antigen were selected for
Materials and methods. Solid bars show how much E antigen was present in
V-infected BHK cells; see Materials and methods for details). Shaded bars show
R NS1-5 VLPs at an MOI = 0.1 (logarithmic scale, right axis).
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NS1-5. For these studies, we selected two clones: BHK
(VEErep/C*-E*-Pac)cl.2.9 (mono-subgenomic replicon) and
BHK(VEErep/C*-E/Pac)cl.8.2 (harboring double-subgenomic
replicon VEErep/C*-E/Pac, which has a genetic structure that
differed from our original replicon VEErep/C-E/Pac by
clustered silent mutations at the start of C that were introduced
to reduce the chance of recombination; indicated by the “*”,
see Materials and methods and Fig. 1B). These two cell lines
were passed side-by-side for 3 weeks, and cells were
cryopreserved at the starting passage level (passage 2, p2)
and at the end of each subsequent week (p5, p9, p13).
Following thawing, the cells were compared side-by-side for
percentage of WNV E-negative cells (Fig. 5A), production of
VLPs (Fig. 5B), and focus size formed by WNR NS1-5 VLPs
(Fig. 5C).
During passaging, BHK(VEErep/C*-E/Pac)cl.8.2 became
enriched with E-negative cells, whereas BHK(VEErep/C*-
E*-Pac)cl.2.9 maintained the same high proportion of E-
positive cells (Fig. 5A). Fig. 5B shows that both cell linesFig. 5. Passaging of selected BHK clones harboring VEErep/C*-E/Pac or VEErep/C
C*-E/Pac) construct. BHK(VEErep/C*-E/Pac)cl.8.2 and BHK(VEErep/C*-E*-Pac)c
level) with weekly cryopreservation. The cultures were then thawed and assayed side
as substrates for VLP production and in focus forming assays. (A) Percent of cells ex
VLPs at MOI = 0.1. (C) Photograph of foci formed by WNR NS1-5 VLPs on cel
different passage levels.produced high levels of VLPs at lower passage levels (where
the percentage of E-positive cells was similar), but at higher
passage levels, the BHK(VEErep/C*-E/Pac)cl.8.2 cultures
produced lower titers of VLPs (Fig. 5B). These data are
consistent with the prediction that E-negative cells present in
the high-passage BHK(VEErep/C*-E/Pac)cl.8.2 cultures were
unable to participate in VLP production, and that these E-
negative cells could serve to limit VLP production, by acting
as substrates for VLP infection that were unable to produce
progeny VLPs. The high-passage BHK(VEErep/C*-E/Pac)
cl.8.2 cultures also produced smaller numbers of infectious
foci than lower-passage cultures (Fig. 5C), and the foci sizes
were smaller (Fig. 5C), consistent with the idea that the
nonpackaging cells in these cultures that were infected
during the initial adsorption period were unable to produce
progeny VLPs (resulting in a lower number of foci formed)
and that nonpackaging cells surrounding packaging cells
infected during the initial adsorption infection soaked up
progeny VLPs hindering spread (and thus reducing focus
size).*-E*-Pac replicons revealed the instability of the double-subgenomic (VEErep/
l.2.9 clones were passaged for 13 passages (with splits of 1:10 at each passage
-by-side by IHC to determine the number of E antigen-expressing cells, and used
pressing E antigen. (B) VLP production at 72 h postinfection with WNR NS1-5
ls {[1] BHK(VEErep/C*-E/Pac)cl.8.2, [2] BHK(VEErep/C*-E*-Pac)cl.2.9} at
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VEEV replicons
To investigate whether the presence of VEEV replicons (and/
or the replicon-encoded WNV proteins) interfered with WNV
replication, we assessed WNV focus morphology on BHK,
BHK(VEErep/C*-E/Pac)cl.8.2, and BHK(VEErep/C*-E*-Pac)
cl.2.9 cells. The side-by-side comparison shown in Fig. 6A
failed to reveal large differences in focus size and morphology
on monolayers of BHK and BHK replicating VEEV replicons
VEErep/C*-E/Pac or VEErep/C*-E*-Pac. Fig. 6A also shows
that cells harboring VEErep/Pac replicon (which does not
express any WNV proteins) produce WNV foci similar to those
seen on BHK.
To verify that packaging cells replicated WNV genomes
similarly, we infected BHK as well as BHK(VEErep/Pac), BHK
(VEErep/C*-E/Pac), and BHK(VEErep/C*-E*-Pac) with VLPs
containing WNV replicon expressing firefly luciferase (Luc)
(WNR C-Luc2A NS1-5, see Fig. 1A). As we and others have
previously published (Rossi et al., 2005; Shi et al., 2002),
expression of Luc produced from replicons is directly
proportional to the level of genome replication and offers a
simple method to measure genome replication. As shown in Fig.
6B, the WNR C-Luc2A NS1-5 replicon replicated equally well
on all cell lines. Taken together, these data indicate that neither
the presence of replicating VEEV RNA nor VEEV proteins
reduced WNV replication, in agreement with previously
published results (Petrakova et al., 2005), and further
demonstrated that the expression of high levels of WNV
structural proteins in these cells had no deleterious effect on
WNV genome replication.
Comparisons of VLP and virus yield revealed that VLPs
were produced more poorly than virus on the packaging cell
lines, suggesting that cis expression of the structural genes and/Fig. 6. Replication of WNV and WNR C-Luc2A NS1-5 in BHK cultures harboring
BHK(VEErep/C*-E*-Pac) were infected with WNV and cell layers were immunost
points following infection with WNR C-Luc2A NS1-5 VLPs; activity per VLP infec
and normalizing this to the number of VLP-infected cells (determined by immunostor inhibition of assembly by the truncated C protein produced
by WNR NS1-5 could result in lower packaging. Fig. 7A shows
that in side-by-side electroporations of packaging cells with
WNV RNA and WNR NS1-5 RNA, virus grew to higher titers
than VLPs. Since there is a lag in the production of infectious
virus from electroporated cells (see Fig. 7A, and results not
shown), we compared production of virus and VLPs in this
packaging cell line following infection with VLPs andWNV. At
both multiplicities of infection (MOI) used in this experiment,
VLPs harboring WNR NS1-5 were produced at lower titers than
live virus (Figs. 7B, C). The growth advantage of virus was also
observed in focus-formation assays. Specifically, WNR NS1-5
foci formed on monolayers of low-passage BHK(VEErep/C*-
E/Pac)cl.8.2 cells were smaller than those formed by WNV
(Figs. 7D, E).
Reporter genes are rapidly lost from WNV replicons during
serial passage
We have previously shown that once introduced into cells,
WNV replicons can be stably maintained for up to 40 passages
(Rossi et al., 2005). However, our previous efforts to make
recombinant WNV with reporter genes in the 3′ UTR met with
rapid loss of reporter gene activity during passage and deletion
of portions of the reporter gene cassette (Zhao and Mason,
unpublished), consistent with a recent report by Doms and co-
workers (Pierson et al., 2005). To examine the stability of
reporter-expressing replicons in our packaging cells, we
examined the effects of serial passage of VLPs on titer and
reporter gene activity. VLPs could be passaged in packaging
cells for multiple passages, achieving titers similar to those
obtained in original infections (results not shown). However,
when VLPs were assayed for reporter activity, a rapid loss of
activity was observed with each passage (Figs. 8A, B). This lossVEEV replicons. (A) BHK, BHK(VEErep/Pac), BHK(VEErep/C*-E/Pac), and
ained at 66 h postinfection. (B) Luc signal in the same cultures at various time
ted cell was determined by infecting parallel wells and determining Luc activity
aining).
Fig. 7. Growth curves of WNV and WNR NS1-5 on BHK(VEErep/C*-E/Pac)cl.8.2 packaging cells. At each time point, media were removed and frozen for
subsequent titration and fresh media were added. The y-axis indicates the cumulative titers of WNVand WNR NS1-5 VLPs produced by the cultures. (A) Release of
WNVandWNRNS1-5 at the indicated times after electroporation in BHK(VEErep/C*-E/Pac)cl.8.2 cells. (B) Release of WNVandWNRNS1-5 at the indicated times
after infection of BHK(VEErep/C*-E/Pac)cl.8.2 cells with MOI = 0.05. (C) Release of WNVand WNR NS1-5 at the indicated times after infection of BHK(VEErep/
C*-E/Pac)cl.8.2 cells with MOI = 5. (D) Foci of WNV stained 48 h after infection of BHK(VEErep/C*-E/Pac)cl.8.2 cell monolayers. (E) Foci of WNR NS1-5 VLPs
stained 48 h after infection of BHK(VEErep/C*-E/Pac)cl.8.2 cell monolayers.
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VLPs with a high level of reporter gene activity from direct
electroporations (p0 in Figs. 8A, B). Despite this limitation,
high titers of reporter gene-encoding VLPs could be produced
from the samples collected from WNV replicon-electroporated
cultures of every packaging cell line we tested.
At the same time that the reporter gene activity was lost from
serial passages of VLPs containing replicons WNR C-Luc2A
NS1-5 and WNR C-bgal2A NS1-5 (see Fig. 1A), a change in
their focus-forming phenotype was observed. Examination of
focus sizes for our minimal replicon (WNR NS1-5) demon-
strated no change between passages p0 and p6 (labeled [1] in
Fig. 8C). However, large foci were present in p0 of WNR C-
Luc2A NS1-5 andWNR C-bgal2A NS1-5, and became the only
detectable population in passage 6 (compare [2] and [3] p0 and
p6 in Fig. 8C). Using an in situ β-galactosidase (βgal) assay, we
were able to clearly demonstrate that the VLPs producing the
large foci in the p0 population of WNR C-bgal2A NS1-5 were
missing the βgal activity, since staining of the monolayer with
X-Gal ([3] in Fig. 8D) revealed that only small foci produced
functional βgal. When the same monolayer was immunos-
tained, large foci that were βgal-negative ([3] in Fig. 8D) werealso detected ([3] in Fig. 8C). These data are consistent with
reports by Mandl and co-authors that TBEV replicons lose
reporter activity (Gehrke et al., 2005), although other labs have
not reported loss of replicon reporters during transient (Harvey
et al., 2004; Jones et al., 2005; Khromykh et al., 1998;
Varnavski and Khromykh, 1999) or continuous packaging of
flavivirus replicons (Harvey et al., 2004).
Analyses of the sequence of the region from the 5′UTR
through the middle of NS1 of passage 6 of our minimal replicon
(WNR NS1-5) showed that no changes from the original cDNA
sequence were detected during 6 passages, consistent with our
inability to detect a change in focus phenotype between p0 and
p6 ([1] in Fig. 8D). However, analyses of the packaged reporter
gene-encoding replicons indicated that the reporter genes were
so rapidly truncated that deletions were identified in cells
infected with VLPs harvested from electroporated cultures.
These analyses included the demonstration that PCR reactions
obtained from the reporter-encoding fragments of cDNAs
derived from cells infected with the p0 VLPs containing either
WNR C-bgal2A NS1-5 or WNR C-Luc2A NS1-5 contained a
ladder of amplification products smaller than the size obtained
from the parental in vitro transcribed RNA (see Supplemental
Fig. 8. Effect of passaging on reporter gene activity and focus phenotype of packaged WNV replicons. (A) Luc activity detected in different passages of WNR C-
Luc2A NS1-5 VLPs; activity per VLP-infected cell was determined by infecting parallel wells of Huh7 cells and determining Luc activity at 30 h and normalizing this
to the number of VLP-infected cells (determined by immunostaining). (B) βgal activity detected in different passages of WNR C-bgal2A NS1-5 VLPs; percent of
VLPs encoding βgal activity at p0 was determined by counting the number of βgal-positive foci on BHK(VEErep/C*-E/Pac)cl.8.2 cell monolayers, and dividing this
by the number of foci stained in double-staining assays (X-Gal andWNVNS1); at other passage levels, parallel wells of Huh7 cells were infected and stained for either
βgal activity or presence of WNV NS1 antigen and the ratios of these numbers were used to determine the percent of VLPs that encoded an active βgal. (C) Foci
produced on BHK(VEErep/C*-E/Pac)cl.8.2 monolayers by [1] WNR NS1-5, [2] WNR C-Luc2A NS1-5, and [3] WNR C-bgal2A NS1-5 VLPs at passage levels p0
and p6. (D) βgal-positive foci in BHK(VEErep/C*-E/Pac)cl.8.2 monolayer infected with p0 passage of WNR C-bgal2A NS1-5, developed and photographed prior to
restaining for WNV NS1 antigen to produce the image shown in panel C. Comparison of the images from these two panels shows that all large antigen-positive foci in
panel C were not stained with X-Gal (D).
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revealed that all contained in-frame deletions eliminating most
of the reporter gene. Interestingly, the entire C protein-coding
region was maintained in the last passage examined (p6; see
Supplemental data). These sequence data and the data showing
that these p6 replicons derived from both reporter gene
replicons produced infectious foci larger than WNR NS1-5
(Fig. 8C) suggest that a full-length C gene rather than the
truncated C in WNR NS1-5 could have a positive effect on
replicon replication or packaging. This finding was further
supported by results from a side-by-side VLP yield experiment
showing that VLPs from p6 reporter gene replicons were
released from packaging cells at titers approximately 10-foldhigher than those produced by p0 or p6 WNR NS1-5 VLPs
(results not shown).
The loss of genetic material from the replicon genomes is
consistent with internal recombination to eliminate the reporter
gene construct, indicating both a strong selective pressure for
reporter-deleted replicon genomes and recombination potential
of the WNV replicon genome. Although we cannot be 100%
certain that the deletions were produced in vivo (rather than in
the in vitro T7 reactions), we were unable to detect any evidence
of truncated genomes in our in vitro transcripts (see Supple-
mental data). Furthermore, attempts to “clone” packaged
replicons that maintained reporter activity failed, sequential
staining of foci of infection of WNR C-bgal2A NS1-5 for βgal
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strongly with our antibody to NS1 often appeared within these
foci, suggesting a high frequency of recombination events.
Despite the generation of intra-molecular recombinants in
our WNV replicons, we were unable to detect recombination
between any of the WNV replicons and the VEEV replicons that
produced live virus. Specifically, two blind-passages on Vero
cells of undiluted passage-6 harvests from all three VLPs shown
in Fig. 8C failed to produce any self-propagating WNV
detectable with antibodies to the WNV E protein using a highly
sensitive immunohistochemical (IHC) staining method.
Discussion
In this study, we describe the construction and application of
novel VEEV replicon-based cell lines that can be used to
package WNV replicons. We have previously described a
highly efficient alphavirus replicon-derived packaging system
for WNV subgenomic replicons (Scholle et al., 2004) that
utilizes sequential electroporations of WNV replicon RNA,
followed by a Sindbis replicon RNA encoding the WNV
structural proteins. The VEEV replicons used to drive the WNV
structural protein expression used in the current study have
several advantages over our previously described Sindbis
replicon system. Specifically, VEEV replicons are less cytotox-
ic, and PurR cell lines expressing high levels of C-prM-E can be
rapidly selected from cultures electroporated with these
replicons. Furthermore, the resulting cell lines can be used for
side-by-side analyses of WNV replicons with altered genetic
structure, allowing more precision in evaluation of WNV
genome function than available by using our previously
described dual-electroporation system. Stable packaging cell
lines have been described previously in CHO cells where
expression of TBEV prM/E proteins was under control of a
CMV promoter (Gehrke et al., 2003) and in another study using
an inducible promoter system to package Kunjin virus replicons
(Harvey et al., 2004). Our system circumvents the lengthy
identification of inducible clones with appropriate tightness of
promoter regulation. Our packaging cell lines produce high
levels of packaged replicons (VLPs) and have proven useful for
characterizing levels of replicon expression, producing reporter
protein-encoding VLPs, and characterizing WNV genome
instability.
The VEEV replicons described in our study are able to
establish persistent replication in BHK cells and express the
WNV E protein, at levels comparable to those expressed in
WNV-infected cells. Although these packaging cell lines
produce slightly lower levels of WNV VLPs than those
obtained by us in sequential electroporation using Sindbis
replicons (Scholle et al., 2004), the VEEV replicon cell lines are
easier to work with, and by using them, we have been able to
readily characterize the genetic stability of a variety of WNV
replicon constructs. The most significant advantage of packag-
ing cell lines compared to the use of sequential electroporations
is the ability to amplify existing VLPs stocks (see below),
reducing the need for template preparation and in vitro
transcriptions.WNV replicon RNAs introduced into our VEEV-replicon-
based packaging cells produced infectious foci and were able to
undergo multiple rounds of replication and packaging, display-
ing properties similar to the system reported by Mandl and
coworkers (Gehrke et al., 2003). As expected, the packaging
cell line produced by this group encoded the prM and E proteins
in the absence of C, so it could only package TBEV replicons
that contained a complete C gene (Gehrke et al., 2003). Our
packaging cell lines contain the C-coding region and efficiently
packaged replicons with either partial or complete C-coding
region. Interestingly, replicons with a full-length C-coding
region yielded higher titers of infectious VLPs than partial-C
genomes. These results demonstrate that C expressed in trans is
able to function in genome packaging in the absence of cis-
expressed C, but that C expressed in cis increases packaging
efficiency, due to either enhanced genome replication and/or
more efficient genome encapsidation (currently under
investigation).
Using our cells, we were able to demonstrate differences in
VLP focus size of packaged replicons containing no reporter
(WNR NS1-5), a 3′ UTR reporter (WNR NS1-5ET2AN), and a
derivative of this latter replicon that had been adapted to
replicate persistently in Huh7 cells, by reducing its replicative
capacity (Rossi et al., 2005). Thus, the size of these foci
correlated with the RNA replication ability of the respective
WNV replicon introduced. Since the packaging cells provide
constant amounts of viral structural proteins with similar supply,
assembly, and cell binding properties, the WNV replicon RNA
becomes the rate-limiting component that determines efficiency
of VLP synthesis and spread of infection. Thus, our packaging
cells should be useful for rapidly evaluating mutations in the
noncoding and nonstructural coding regions of the WNV
genome that alter replication, by merely comparing the size of
foci formed on packaging cells. Interestingly, the presence of
high levels of trans-expressed WNV C/prM/E protein in these
cells did not appear to have any effect on the growth of WNVor
the replication of WNV replicons.
Our analyses also showed that these packaging cells
produced higher yields of virus than VLPs following either
synthetic RNA transfection or infection with virus or a minimal
VLP (WNR NS1-5) generated from the same reverse genetics
system. There are several possible reasons for this difference.
One is that the trans-expressed forms of C, prM, or E (even
though they are expressed at levels higher than that found in
WNV infection) were not as efficiently incorporated into VLPs
as cis-expressed virally encoded structural proteins. Alterna-
tively, the fragments of C and/or signal sequence to NS1
encoded in our “minimal” replicon interfere with genome
encapsidation, or there are some specific packaging signals in
the region deleted from our replicon genome that contribute to
packaging efficiency.
Our prototype packaging cell lines used noncytopathic,
double-subgenomic VEEV replicons to express antibiotic
resistance needed to maintain the VEEV replicon and to
produce the WNV structural proteins. Although cells with these
replicons were very useful for packaging, sequential passaging
of the cells resulted in the loss of the WNV structural protein
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codon in the WNV coding region (results not shown) of the
replicons present in one WNVantigen-negative cell clone, but it
is also possible that nonsense mutations in the WNV coding
region and/or deletion of the WNV coding region could all
produce cell lines that would beWNVantigen-negative and thus
unable to package WNV replicons. To overcome this problem,
we fused the WNV structural proteins with an antibiotic
resistance gene to create a noncytopathic VEEV replicon
expressing a monocistronic message that was capable of
maintaining the WNV proteins for long-term passaging. The
cell line containing this construct showed a slight growth defect
relative to parental BHK cells, but readily packaged replicons
for multiple passages. Nevertheless, the growth retardation of
this cell line and the loss of WNVantigen from cells expressing
the double-subgenomic VEEV replicon suggest that the WNV
C/prM/E proteins have some toxic effects on cells. Other
investigators have circumvented toxicity problems with flavi-
virus structural proteins through the use of inducible promoter
systems (Harvey et al., 2004) or the identification of cell lines
that are less sensitive to these toxic effects, such as CHO cells
(Gehrke et al., 2003).
Flavivirus replicons expressing heterologous genes have a
wide range of potential applications from monitoring changes
in RNA replication via reporter readout to their use as
potential vaccine vectors expressing immunogens. VLPs can
serve as a convenient delivery vehicle for those replicons,
displaying infectious properties very similar to those of the
virus they are derived from (Scholle et al., 2004). Our data and
those of other investigators demonstrate that encapsidation of
reporter-containing replicons into VLPs is possible at titers
high enough to be useful for a variety of applications.
However, in this manuscript, we identified a significant
selective pressure against encapsidation of reporter gene
expressing replicons when they are passaged on a packaging
cell line. Even after just one passage, approximately 90% of
reporter activity was lost, despite continued efficient VLP
production for multiple passages. These results can be
explained by a strong selection for reporter-deficient replicons
that replicate to higher levels than their reporter-containing
counterparts that are, therefore, preferentially packaged and
transduced to naive cells in each subsequent passage. After a
few rounds of passaging, all reporter-expressing replicons
were eliminated from our preparations. Loss of the reporter
gene activity correlated with a deletion of the genes encoding
the reporter genes. This loss is easily explained by the
enhanced fitness and spreading of the reporter-deleted
replicons; these replicons produced larger foci on cells than
their parental reporter gene-encoding replicons, consistent with
their apparent superior fitness.
Despite the fact that WNV replicons lose their reporter genes,
this problem can be readily overcome by using a highly efficient
transfection or high MOI infection to introduce flavivirus
replicons into the packaging cells and produce VLPs in a single
reaction without the need for multiple passages. Using this
method, along with polyethylene glycol precipitation, we have
readily obtained preparations of reporter gene-bearing repliconswith titers of over 108 infectious units (iu) per ml (data not
shown).
The results of these studies clearly demonstrate the
significant selective pressures to eliminate unneeded genetic
material within WNV genomes that are repeatedly repackaged.
This loss of information is not strictly related to genome
packaging constraints since some of our reporter-encoding
WNV replicon genomes are similar in size to the WNV genome.
The loss of reporter genes in these VLP passaging experiments
stands in stark contrast to the maintenance of reporter genes in
cell lines bearing cell-adapted WNV replicons (Rossi et al.,
2005). In the case of these cell-adapted replicons, the replicon-
encoded reporter genes have been maintained for dozens of
passages in the presence of the selective antibiotic (Rossi et al.,
2005), and the resistance marker genes are also maintained for
weeks in the absence of antibiotic application (results not
shown). Taken together, these findings demonstrate that the
selective pressures placed on WNV replicon genomes are
significantly different in cell-restricted (persistent infection) and
spreading (VLP transmission) environments. These studies
therefore confirm the elegant genetic simplicity of these agents,
and the continuous genetic pressure that maintains compact and
effective genomes.
Materials and methods
Cell lines
BHK, Vero, Huh7, and a Huh7-derived cell line (Huh7 cl
1.1) harboring WNR NS1-5ET2AN have been described
previously (Rossi et al., 2005).
WNV replicons
A prototype WNV replicon (WNR NS1-5) and a WNV
replicon harboring the HIV tat gene fused to the gene for
neomycin phophotransferase II (neo) via the FMDV autocata-
lytic proteinase 2A (WNR NS1-5ET2AN) have been described
(Rossi et al., 2005) (see Fig. 1A). Two similar WNR NS1-5
replicons were used in our studies, both had the same overall
genetic structure, but one contained a sense mutation at position
2242 A–G, codons K72E in NS1; in all assays, we detected no
difference in replication or packaging of these two replicons. To
help in the characterization of WNV replicon packaging and
assembly, two additional replicons were constructed from the
same cDNAs (Rossi et al., 2005) used to make the other
replicons (Fig. 1A). One of these (designated WNR C-Luc2A
NS1-5) was created by insertion of the Luc gene (luc) between
the C and NS1 protein-encoding regions of the WNV genome.
This construct contained the sequences encoding all of C and
the first 8 codons of the anchor of C (which also serves as the
signal sequence for prM), fused in-frame to the initiation codon
of Luc. The luc gene was then followed by FMDV 2A and the
NS1 signal peptide (see Fig. 1A). A βgal construct with a
similar structure was generated by insertion of the lacZ gene
followed by the FMDV 2A coding region in the same site used
to engineer WNR C-Luc2A NS1-5, generating a construct
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replicon RNAs were synthesized from SwaI-linearized plasmid
DNAs using the T7 Megascript kit (Ambion) and introduced
into BHK cells by electroporation (Rossi et al., 2005).
Development of VEEV replicons expressing WNV structural
proteins
Fig. 1B shows the schematic diagrams of the VEEV
replicons used in this study; replicon VEErep/Pac is the same
as 5′VEErep/S/Pac (Petrakova et al., 2005). Replicon VEErep/
C-E/Pac was created by inserting the WNV C/prM/E cassette
from a plasmid encoding SRWNC/prM/E (described in Scholle
et al., 2004) downstream of a second subgenomic promoter
added to the cDNA encoding VEErep/Pac (see Fig. 1B). The
sequence encoding the first 29 amino acids of C of VEErep/C-
E/Pac cDNAwas changed by introduction of 36 clustered silent
mutations to yield replicon VEErep/C*-E/Pac. These mutations
ablated the cyclization signal needed for flavivirus replication
(Corver et al., 2003; Khromykh et al., 2001; Lo et al., 2003),
providing a safeguard against production of viable live virus by
recombination with WNV replicon genomes that were subse-
quently expressed in these cells (see below). A single-
subgenomic VEEV replicon was created by fusing the WNV
C/prM/E cassette of VEErep/C*-E/Pac to the pac gene through
a linker consisting of the first 9 codons of NS1 fused to the last
25 codons of NS2B, followed by 2 codons of NS3 fused directly
to FMDV 2A (see Fig. 1B). To reduce the chance of
recombination between this VEEV replicon and the WNV
replicon genomes, 32 clustered silent mutations were intro-
duced into the coding sequence of the signal peptide of NS1 in
replicon VEErep/C*-E*-Pac. VEEV replicon RNAs were
produced by linearizing plasmid DNAs with MluI, and
generating transcripts by using a MegaScript SP6 kit (Ambion).
BHK cells persistently expressing VEEV replicons were
selected by culturing cells, electroporated with these synthetic
RNAs, in the presence of 10 μg/ml of Pur.
IHC staining and quantitative ELISA
IHC staining and ELISA were performed as previously
described using acetone/methanol-fixed cell monolayers or
Triton X-100-solubilized cell lysates (Rossi et al., 2005).
Immune reagents included mouse hyperimmune ascites fluids
specific for WNV or VEEV (supplied by R.B. Tesh, UTMB),
or monoclonal antibodies (MAb) to WNV E (7H2; Biore-
liance), flavivirus E (D1-4G2; Gentry et al., 1982), or WNV
NS1 (6H4; generously supplied by E. Konishi, Kobe
University, Kobe, Japan). Affinity purified goat anti-mouse
HRP-conjugated IgG (KPL) was used as a secondary antibody
for both types of assays. E protein expression levels were
determined using ELISA data by comparing values from
VEEV replicon-expressing cells to the values obtained with
dilutions of a lysate of WNV-infected BHK cells harvested at
30 h after infection (dilutions were prepared in a lysate
obtained from uninfected BHK cells, to keep the protein
concentration constant; standards were coated on the plates atthe same protein concentration as test samples, and run in each
assay). These assays produced a linear standard curve that
revealed that WNV E antigen levels were nearly constant
between 24 and 36 h postinfection with WNV, and increased
slightly at later time points. Using the standard curve obtained
from the WNV-infected sample, the amounts of E present in
the VEEV replicon cell lines were determined; these values are
displayed relative to the value of “100” which was assigned to
the amount of antigen present in BHK cells 30 h after infection
with WNV.
VLP production
VLPs were produced in packaging cells by infection with
previously derived VLPs, electroporation with 5 to 10 μg of
WNV replicon RNAs synthesized in vitro (see above), or
electroporation with replicon RNAs present in total RNA
isolated from cells (Huh7 cl 1.1) harboring a persistently
replicating WNV replicon. After infection or transfection, the
cells were maintained on media with 1% fetal bovine serum
(FBS; low serum concentration was used to prevent cell
overgrowth) and VLP-containing supernatants were collected at
indicated times and frozen for subsequent analysis.
VLP titrations
VLPs titers were determined by infecting monolayers of
Huh7 cells with small volumes of serial dilutions of VLP
preparations, and refeeding with media containing 1% FBS after
a 60 min adsorption period. Cell layers were fixed 24–30 h later
and subjected to IHC staining as described above. The number
of immunopositive cells was determined in wells and used to
calculate VLP titers which were expressed as iu/ml.
VLP plaque assay
VLP foci (or plaques) were visualized on monolayers of
packaging cells BHK(VEErep/C-E/Pac), BHK(VEErep/C*-E/
Pac), or BHK(VEErep/C*-E*-Pac) by infection as described
above and then refeeding with a semisolid overlay containing
0.6% tragacanth (MP Biomedicals) to prevent VLP diffusion.
Cell layers were fixed 2 to 4 days later and immunostained as
described above.
Serial passaging of VLPs using packaging cells
Low passage BHK(VEErep/C*-E/Pac)cl.8.2 cells were
aliquoted and stored in liquid nitrogen. After thawing, cells
were plated in 12-well plates for 16 h before infecting. The first
VLP passage was performed with MOI = 0.5 using samples
harvested at 60 h postelectroporation. All other passages were
performed by adding 200 μl of a 1:10 dilution of VLPs from
previous passage to cell layers and rocking plates for 1 h. After
inoculums were removed, 1.0 ml of 1% FSB media was added
to each well. VLP-containing media were harvested at 3 days
after the beginning of infection. Side-by-side titrations com-
pleted at the end of the passaging experiment revealed that the
208 R. Fayzulin et al. / Virology 351 (2006) 196–209MOI used in these infections was between 0.1 and 0.5 iu/cell at
each passage level.
Determination of WNV genome copies
Duplicate BHK cell monolayers were infected with VLPs,
and 48 h later RNA samples were harvested from one set of
wells and the remaining wells were immunostained (see above)
to determine the number of VLP-infected cells. Levels of WNV
RNAwere determined using a dot-blot hybridization assay with
a slight modification of previously described methods (O'Don-
nell et al., 2001), using dilutions of in vitro transcribed WNV
replicon RNA as a standard. The number of genome copies
detected was then normalized to the number of VLP-infected
cells (from the IHC-stained wells) to determine the genome
copy number per VLP-infected cell.
Luc assays
BHK or Huh7 monolayers prepared in 96-well black-wall
plates were infected with dilutions of WNR C-Luc2A NS1-5
VLPs prepared in media with 1% FBS. Plates were rocked for
an hour to facilitate binding and then incubated at 37 °C for up
to 30 h. Media was removed at the indicated times, and Luc
assay reagent containing 40 mM Tricine, 8 mM magnesium
acetate, 33 mM of DTT, 0.13 mM EDTA, 0.1% Triton X-100,
0.53 mM ATP, 0.47 mM D-luciferin (Molecular Imaging
Products Company), and KOH to pH 7.8 was added to the
cell monolayers. Plates were agitated for 30 s and light output
was measured in a TR717 microplate luminometer (Applied
Biosystems). To control for differences in individual experi-
ments, assays included side-by-side determinations of light
output from a dilution series prepared from a Luc standard
(Promega), and the standard curve generated from these
samples was used to determine the relative light units (RLU)
of Luc present in test samples.
βgal staining
Cells infected with WNR C-bgal2A NS1-5 VLPs were fixed
using cold acetone/methanol, rehydrated with PBS, and then
incubated in X-Gal solution (0.5 mg/ml X-Gal, 5 mM
potassium-ferricyanide, 5 mM potassium-ferrocyanide, 1 mM
MgCl2 in PBS) for 30–60 min. In some cases, the X-Gal-stained
monolayers were rinsed with PBS and immunostained as
described above.
Replicon RNA isolation and sequencing
Sequence analysis of packaged replicons were determined
by infecting Vero cells with VLPs and then harvesting total
cellular RNA at 24 h postinfection and subjecting it to reverse
transcription (RT) and PCR using a high-fidelity polymerase
(Accu-Taq: Sigma) by a method similar to one we have
previously described (Rossi et al., 2005). PCR amplification
was accompanied using sense primer 5′-AGTAGTTCGCCT-
GTGTGAGC and antisense primer 5′-CCGAGTGCTGGT-GAGACC producing a cDNA fragment that included the 5′
UTR, C, reporter insert, and a part of NS1. The PCR reaction
products were resolved by agarose gel electrophoresis,
fragments were excised, purified, and then subjected to
automated DNA sequencing at the UTMB Protein Chemistry
Core Facility.
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